Partilhar
Informação da revista
Artigos originais
Could the unfortunate outcome of pediatric acute myocarditis be predicted? Factors contributing to a poor outcome in myocarditis
Stasa Krasic, Sergej Prijic, Sanja Ninic, Dejan Nesic, Bojko Bjelakovic, Gordana Petrovic, Ivana Cerovic, Vladislav Vukomanovic
Rev Port Cardiol. 2021;40:631-8
Open access
Artigos Originais
Coméntario editorial
Risk prediction for adverse events in pediatric acute myocarditis: Are we there yet?
Soham Dasgupta
Rev Port Cardiol. 2021;40:639-40
Open access
Temporal trends of lipid control in very high cardiovascular risk patients
Paulo Maia Araújo, Alzira Nunes, Sofia Torres, Carlos Xavier Resende, Sérgio Machado Leite, Joana Duarte Rodrigues, Sandra Amorim, Elisabete Martins, ... Maria Júlia Maciel
Rev Port Cardiol. 2021;40:641-8
Open access
Artigos Originais
Coméntario editorial
Heaven can wait… for lipid control in very high cardiovascular risk patients
Alberto Mello e Silva
Rev Port Cardiol. 2021;40:649-51
Open access
Balloon pulmonary angioplasty protocol in a Portuguese pulmonary hypertension expert center
Rita Calé, Filipa Ferreira, Ana Rita Pereira, Carla Saraiva, Ana Santos, Sofia Alegria, Débora Repolho, Sílvia Vitorino, ... Hélder Pereira
Rev Port Cardiol. 2021;40:653-65
Open access
Artigos Originais
Coméntario editorial
Balloon pulmonary angioplasty – welcome to chronic thromboembolic pulmonary hypertension treatment
Nick H. Kim
Rev Port Cardiol. 2021;40:667-8
Open access
Adesão à terapêutica com anticoagulantes diretos em doentes com fibrilhação auricular não valvular – uma análise de mundo real
Catarina Brízido, António Miguel Ferreira, Pedro Lopes, Christopher Strong, Gustavo Sá Mendes, Francisco Fernandes Gama, Anaí Durazzo, Gustavo Rocha Rodrigues, ... Miguel Mendes
Rev Port Cardiol. 2021;40:669-75
Open access
Artigos Originais
Coméntario editorial
Patient adherence to direct oral anticoagulants: To take or not to take, is it a patient's choice?
Cristina Gavina
Rev Port Cardiol. 2021;40:677-8
Open access
Clinical value of the combined use of P-wave dispersion and troponin values to predict atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation
Metin Ocak, Mustafa Begenc Tascanov
Rev Port Cardiol. 2021;40:679-84
Open access
Artigos Originais
Coméntario editorial
Serum biomarkers and the electrocardiogram: Best friends forever?
Pedro Silva Cunha
Rev Port Cardiol. 2021;40:685-6
Open access
Estado da arte
SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
José Silva-Cardoso, Aurora Andrade, Dulce Brito, Jorge Ferreira, Cândida Fonseca, Marisa Peres, Fátima Franco, Brenda Moura
Rev Port Cardiol. 2021;40:687-93
Open access
Caso clínico
Exercise-induced left fascicular block: A forgotten sign of coronary disease
Virginia Ruiz-Pizarro, Julián Palacios-Rubio, Miguel Ángel Cobos-Gil
Rev Port Cardiol. 2021;40:695.e1-695.e4
Open access
Comentário editorial
2020 European Society of Cardiology Core Curriculum for the Cardiologist. Is it time for change in the Portuguese cardiology training program?
Kevin Domingues, Lino Gonçalves, Maria João Vidigal, Felix C. Tanner, Miguel Mendes
Rev Port Cardiol. 2021;40:697.e1-697.e4
Open access
Imagem em cardiologia
Massive thrombus over an aneurysmatic left main coronary artery: Non-interventional therapy?
Kristian Rivera, Diego Fernández-Rodríguez, Marta Zielonka, Juan Casanova-Sandoval
Rev Port Cardiol. 2021;40:699-700
Open access
Intracavitary mass in echocardiography: A rare manifestation of serous ovarian carcinoma
Arnold Mendez-Toro, Andres Felipe Linares-Vaca
Rev Port Cardiol. 2021;40:701-2
Open access
Carta ao editor
Prognostic impact of high flow nasal cannula compared to noninvasive positive-pressure ventilation in the treatment of acute pulmonary edema
Williams Hinojosa, Carolina Iglesias, Silvio Vera, Marta Marcos, Aitor Uribarri, Itziar Gómez, Gemma Pastor
Rev Port Cardiol. 2021;40:703-5
Open access
Conteúdo especial sobre COVID-19
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
- Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.